Sartorius Aktiengesellschaft Company Description

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide.

The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products.

It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions.

The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries.

The company was founded in 1870 and is headquartered in Göttingen, Germany.

Sartorius Aktiengesellschaft

Country	Germany
Founded	1870
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	14,042
CEO	Michael Grosse

Contact Details

Address: Otto-Brenner-Strasse 20 Göttingen, 37079 Germany
Phone	49 551 308 0
Website	sartorius.com

Stock Details

Ticker Symbol	SRT3
Exchange	Deutsche Börse Xetra
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	DE0007165631
SIC Code	3826

Key Executives

Name	Position
Patricia Spannagel	Head of Quality Assurance - Mechatronics Division Goettingen
Ralf Mohrschladt	Physicist and Head of Supply Chain Management - Germany
Petra Muller	Head of Investor Relations
Maurice Phelan	President of Sartorius North America
Dr. Theo Thijssen	President of Environmental Technology Division